| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |